Common GI Side Effects of Vascepa
Vascepa (icosapent ethyl) commonly causes gastrointestinal issues like constipation, diarrhea, nausea, and abdominal discomfort. These occur in about 3-5% of patients in clinical trials, higher than placebo rates.[1]
How Often Do They Happen?
In the pivotal REDUCE-IT trial, GI events included:
- Constipation: 5%
- Nausea: 4%
- Diarrhea: 3%
- Abdominal pain: 3%
Rates were dose-dependent and more frequent early in treatment, often resolving over time.[1][2]
Why Does Vascepa Cause These?
As a purified EPA omega-3, it alters gut motility and bile acid handling, irritating the GI tract in sensitive patients. Taking it with food reduces nausea and diarrhea.[2]
Are They Serious or Long-Term?
Most are mild and transient; severe cases like pancreatitis or GI bleeding are rare (<1%). No increased risk of ulcers or bleeding in trials, unlike some fish oils.[1]
Compared to Lovaza or Other Fish Oils
Vascepa has fewer eructation (fishy burps) reports (1-2%) than Lovaza (4-11%), due to no DHA component. Still, constipation edges higher than statins alone.[2][3]
Tips for Managing GI Issues
Split doses, eat with meals, or use antacids. Consult a doctor if persistent; switching to generic icosapent ethyl doesn't change profile.[2]
Who Gets Them Most?
Higher in women, elderly, or those with prior GI history. REDUCE-IT subset analysis showed no excess risk in triglycerides >500 mg/dL patients.[1]
[1]: FDA Vascepa Label
[2]: REDUCE-IT Trial (NEJM)
[3]: Drugs.com Vascepa Side Effects